0 évaluation0% ont trouvé ce document utile (0 vote)
635 vues1 page
Morphine Peak 20 min Trade Name Astramorph Onset rapid Classification Opioid analgesic Duration 4-5 hrs dose 2mg-4mg Route IV Time / frequency q 3 hrs Normal dosage range rapid administration may lead to increased respiratory depression, hypotension, and circulatory collapse For IV meds, compatibility with IV drips and / or solutions solution is colorless; do not administer discolored solution Common side effects confusion, sedation, respiratory DEPRES
Morphine Peak 20 min Trade Name Astramorph Onset rapid Classification Opioid analgesic Duration 4-5 hrs dose 2mg-4mg Route IV Time / frequency q 3 hrs Normal dosage range rapid administration may lead to increased respiratory depression, hypotension, and circulatory collapse For IV meds, compatibility with IV drips and / or solutions solution is colorless; do not administer discolored solution Common side effects confusion, sedation, respiratory DEPRES
Droits d'auteur :
Attribution Non-Commercial (BY-NC)
Formats disponibles
Téléchargez comme DOC, PDF, TXT ou lisez en ligne sur Scribd
Morphine Peak 20 min Trade Name Astramorph Onset rapid Classification Opioid analgesic Duration 4-5 hrs dose 2mg-4mg Route IV Time / frequency q 3 hrs Normal dosage range rapid administration may lead to increased respiratory depression, hypotension, and circulatory collapse For IV meds, compatibility with IV drips and / or solutions solution is colorless; do not administer discolored solution Common side effects confusion, sedation, respiratory DEPRES
Droits d'auteur :
Attribution Non-Commercial (BY-NC)
Formats disponibles
Téléchargez comme DOC, PDF, TXT ou lisez en ligne sur Scribd
Generic Name Trade Name Classification Dose Route Time/frequency
morphine Astramorph Opioid analgesic 2mg-4mg IV Q 3 hrs Peak Onset Duration Normal dosage range 20 min rapid 4-5 hrs Usual starting dose for moderate to severe pain in opioid-naive patients--4-10 mg q 3-4 hr. Rate: Administer 2.5-15 mg over 4-5 min. Rapid administration may lead to increased respiratory depression, hypotension, and circulatory collapse Why is your patient getting this medication For IV meds, compatibility with IV drips and/or solutions Pain Solution is colorless; do not administer discolored solution. Dilute with at least 5 ml of sterile water or 0.9% NaCl for injection to a concentration of 0.5-5 mg/ml Y-Site Incompatibility: amphotericin B cholesteryl sulfate, azithromycin, cefepime, doxorubicin liposome, minocycline, phenytoin, sargramostim Mechanism of action and indications Nursing Implications (what to focus on) (Why med ordered) Contraindications/warnings/interactions Binds to opiate receptors in the CNS. Alters the perception of Hypersensitivity, Some products contain tartrazine, bisulfites, or and response to painful stimuli while producing generalized alcohol and should be avoided in patients with known hypersensitivity CNS depression Common side effects confusion, sedation, RESPIRATORY DEPRESSION, hypotension, constipation Interactions with other patient drugs, OTC or herbal Lab value alterations caused by medicine medicines (ask patient specifically) May ↑ plasma amylase and lipase levels Detrol: Coadministration of narcotic analgesics with anticholinergic agents may have additive central nervous Be sure to teach the patient the following about this medication system (CNS) and gastrointestinal (GI) system effects, and Instruct patient how and when to ask for pain medication. May cause increase the risk of severe constipation or paralytic ileus and drowsiness or dizziness. Caution patient to call for assistance when CNS depression. ambulating or smoking and to avoid driving or other activities Baclofen: Central nervous system- and/or respiratory- requiring alertness until response to medication is known. Advise depressant effects may be additively or synergistically patient to change positions slowly to minimize orthostatic hypotension. increased in patients taking multiple drugs that cause these Caution patient to avoid concurrent use of alcohol or other CNS effects, especially in elderly or debilitated patients. depressants with this medication. Encourage patients who are Norvasc: The concomitant administration of agents with immobilized or on prolonged bedrest to turn, cough, and breathe hypotensive effects and psychotherapeutic agents (e.g., deeply every 2 hr to prevent atelectasis. anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics), narcotic analgesics, alcohol, or muscle relaxants may additively increase hypotensive and/or central nervous system depressant effects. Nursing Process- Assessment Assessment Evaluation (Pre-administration assessment) Why would you hold or not give this med? Check after giving Assess type, location, and intensity of pain prior to If respiratory rate is <10/min, assess level of Decrease in severity of pain and 20 min (peak) following IV administration. sedation. Toxicity (administer Narcan) without a significant alteration in Assess level of consciousness, blood pressure, level of consciousness or pulse, and respirations before and periodically respiratory status during administration. Assess bowel function routinely.